EV Nickel Inc. | WebDisclosure

Basculer en Français

10372	Companies
216173	Keywords
145882	Articles
114461	Press releases

Home
Companies
EV Nickel Inc.

PRESS RELEASE

published on 05/08/2024 at 07:30, 2 years ago

APONTIS PHARMA starts financial year 2024 with growth in revenue of Single Pill combinations and positive net result – forecast for full-year 2024 confirmed
APONTIS PHARMA reports growth in revenue of Single Pill combinations and positive net result in Q1 2024, confirming forecast for full-year 2024. Improved EBITDA and new sales model aims to increase revenue further

Revenue Growth Forecast APONTIS PHARMA Single Pill Combinations Q1 2024
BRIEF

published on 04/16/2024 at 13:05, 2 years ago

EV Nickel Inc. Launches Comprehensive 2024 Exploration Program

Sustainable Mining Clean Energy Nickel Exploration Canadian Mining Mineral Finance
BRIEF

published on 04/16/2024 at 13:05, 2 years ago

EV Nickel Inc. lance un programme d'exploration complet pour 2024

Énergie Propre Exploitation Minière Durable Exploitation Minière Canadienne Exploration Du Nickel Financement Minier
PRESS RELEASE

published on 04/16/2024 at 13:00, 2 years ago

EV Nickel Announces Fully Funded Exploration Program
EV Nickel Inc. announces its 2024 exploration program focusing on its significant Nickel deposits in Timmins, Ontario, following a $5.1M financing. The program includes geophysical surveys, metallurgical test work, and diamond drilling

Diamond Drilling 2024 Exploration Program EV Nickel Inc. Nickel Deposits Timmins Ontario
PRESS RELEASE

published on 04/15/2024 at 14:01, 2 years ago

Original-Research: Apontis Pharma AG (von Montega AG): Kaufen
Montega AG stuft Apontis Pharma AG hoch und aktualisiert das Kursziel auf 16,50 EUR aufgrund neuer Vertriebsstrategie und Kooperation mit Novartis. Analyst Tim Kruse empfiehlt Kauf

Montega AG APONTIS PHARMA AG Kursziel 16,50 EUR Vertriebsstrategie Kooperation Novartis
BRIEF

published on 04/05/2024 at 10:22, 2 years 1 month ago

APONTIS PHARMA Secures Five-Year Distribution and Marketing Deal with Novartis for Asthma Medications

Pharmaceutical Industry Financial Forecast APONTIS PHARMA Asthma Medications Novartis
BRIEF

published on 04/05/2024 at 10:22, 2 years 1 month ago

APONTIS PHARMA conclut un accord de distribution et de commercialisation de cinq ans avec Novartis pour des médicaments contre l'asthme

Prévisions Financières Industrie Pharmaceutique PHARMA APONTIS Médicaments Contre L'asthme Novartis
PRESS RELEASE

published on 04/05/2024 at 10:17, 2 years 1 month ago

APONTIS PHARMA enters five-year distribution and marketing agreement with Novartis for two asthma medications and raises forecast
APONTIS PHARMA partners with Novartis for asthma medications distribution and marketing, raising forecast for 2024 financial year

Distribution Agreement APONTIS PHARMA Asthma Medications Novartis Forecast Increase
BRIEF

published on 04/05/2024 at 10:15, 2 years 1 month ago

APONTIS PHARMA AG Enhances Forecast Following Agreement with Novartis

APONTIS PHARMA AG Financial Growth Forecast Upgrade Novartis Agreement Asthma Medications
BRIEF

published on 04/05/2024 at 10:15, 2 years 1 month ago

APONTIS PHARMA AG améliore ses prévisions suite à un accord avec Novartis

Croissance Financière APONTIS PHARMA AG Mise À Niveau Des Prévisions Accord Novartis Médicaments Contre L'asthme

Accesswire

Published on 05/09/2026 at 01:55, 1 day ago

Prospect Ridge Announces Board Resignation
Published on 05/09/2026 at 01:40, 1 day ago

Findev Inc. Issues Corrective Disclosure
Published on 05/09/2026 at 01:30, 1 day ago

Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 1 day 2 hours ago

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:01, 1 day 3 hours ago

Water Ways Announces Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 05/09/2026 at 19:05, 7 hours 23 minutes ago

LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day 5 hours ago

EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 1 day 7 hours ago

EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 1 day 7 hours ago

Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/08/2026 at 18:29, 1 day 7 hours ago

Designated Person Notification

Les Echos

Published on 05/07/2026 at 19:15, 2 days 7 hours ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 2 days 7 hours ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 2 days 7 hours ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 2 days 7 hours ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 2 days 7 hours ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE